Minimally invasive orbital decompression: Local anesthesia and hand-carved bone

Archives of Ophthalmology

Volumn 123, Issue 12, 2005, Pages 1671-1675

  Ben Simon, Guy J ^a,b   Schwarcz, Robert M ^a   Mansury, Ahmad M ^a   Wang, Lillian ^a   McCann, John D ^a   Goldberg, Robert A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b JULES STEIN EYE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; DECOMPRESSION SURGERY; DIPLOPIA; EXOPHTHALMOS; FEMALE; HUMAN; INTRAOCULAR PRESSURE; MALE; MINIMALLY INVASIVE SURGERY; OPHTHALMODYNAMOMETRY; PATIENT CODING; PATIENT INFORMATION; PATIENT SATISFACTION; PRIORITY JOURNAL; SLIT LAMP; SURGICAL PATIENT; SURGICAL TECHNIQUE; TREATMENT OUTCOME; VISUAL ACUITY; ZYGOMA;

ADIPOSE TISSUE; ADULT; AGED; ANESTHESIA, LOCAL; DECOMPRESSION, SURGICAL; EXOPHTHALMOS; FEMALE; GRAVES OPHTHALMOPATHY; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; OPHTHALMOLOGIC SURGICAL PROCEDURES; ORBIT; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; SURGICAL PROCEDURES, MINIMALLY INVASIVE; VISUAL ACUITY;

EID: 28944443621     PISSN: 00039950     EISSN: 00039950     Source Type: Journal    
DOI: 10.1001/archopht.123.12.1671     Document Type: Article

References (34)

1. Bartalena L, Pinchera A, Marcocci C. Management of Graves' ophthalmopathy: reality and perspective. Endocr Rev. 2000;21:168-199.
2. Weetman A, Cohen SL, Gatter KC, Fells P, Shine B. Immunohistochemical analysis of the retrobulbar tissues in Graves' ophthalmopathy. Clin Exp Immunol. 1989;75:222-227.
3. Kubota S, Gunji K, Ackrell BAC, et al. The 64-kilodalton eye muscle protein is the flavoprotein subunit of mitochondrial succinate dehydrogenase: the corresponding serum antibodies are good markers of an immune-mediated damage to the eye muscle in patients with Graves' hyperthyroidism. J Clin Endocrinol Metab. 1998;83:443-447.
4. McGregor A. Has the target autoantigen for Graves' ophthalmopathy been found? Lancet. 1998;352:595-596.
5. Grubeck-Loebenstein B, Treib K, Sztankay A, Holter W, Anderl H, Wick G. Retrobulbar T cells from patients with Graves' ophthalmopathy are CD8+ and specifically recognize autologous fibroblasts. J Clin Invest. 1994;93:2738-2743.
6. Heufelder A, Herterich S, Ernst G, Bahn RS, Heufelder AE. Analysis of retroorbital T cell antigen receptor variable region gene usage in patients with Graves' ophthalmopathy. Eur J Endocrinol. 1995;132:266-277.
7. Perros P, Crombie AL, Kendall-Taylor P. Natural history of thyroid-associated ophthalmopathy. Clin Endocrinol (Oxf). 1995;42:45-50.
8. Bartley G, Fatourechi V, Kadrmas EF, et al. Clinical features of Graves' ophthalmopathy in an incidence cohort. Am J Ophthalmol. 1996;121:284-290.
9. Fatourechi V, Bergstralh EJ, Garrity JA, et al. Predictors of response to transantral orbital decompression in severe Graves' ophthalmopathy. Mayo Clin Proc. 1994;69:841-848.
10. Gerding M, Terwee CB, Dekker FW, Koornneef L, Prummenl MF, Wiesinga WM. Quality of life in patients with Graves' ophthalmopathy is markedly decreased: measurement by the medical outcomes study instrument. Thyroid. 1997;7:885-889.
11. Terwee C, Dekker FW, Mouritus MP, et al. Interpretation and validity of changes in scores on the Graves' ophthalmopathy quality of life questionnaire (GO-QOL) after different treatments. Clin Endocrinol (Oxf). 2001;54:391-398.
12. Baylis H, Call NB, Shibata CS. The transantral orbital decompression (Ogura technique) as performed by the ophthalmologist: a series of 24 patients. Ophthalmology. 1980;87:1005-1012.
13. Anderson R, Linberg JV. Transorbital approach to decompression in Graves' disease. Arch Ophthalmol. 1981;99:120-124.
14. McCord C. Current trends in orbital decompression. Ophthalmology. 1985;92:21-33.
15. Lyons CJ, Rootman J. Orbital decompression for disfiguring exophthalmos in thyroid orbitopathy. Ophthalmology. 1994;101:223-230.
16. Paridaens DA, Verhoeff K, Bouwens D, van Den Bosch WA. Transconjunctival orbital decompression in Graves' ophthalmopathy: lateral wall approach ab interno. Br J Ophthalmol. 2000;84:775-781.
17. Cornblath W. Thyroid eye disease. Curr Treat Options Neurol. 2000;2:401-406.
18. Eloy P, Trussart C, Jouzdani E, Collet S, Rombaux P, Bertrand B. Transnasal endoscopic orbital decompression and Graves' ophthalmopathy. Acta Otorhinolaryngol Belg. 2000;54:165-174.
19. Goldberg RA, Kim AJ, Kerivan KM. The lacrimal keyhole, orbital door jamb, and basin of the inferior orbital fissure: three areas of deep bone in the lateral orbit. Arch Ophthalmol. 1998;116:1618-1624.
20. Graham SM, Brown CL, Carter KD, Song A, Nerad JA. Medial and lateral orbital wall surgery for balanced decompression in thyroid eye disease. Laryngoscope. 2003;113:1206-1209.
21. Kalmann R, Mouritz MP, van der Pol JP, Koornneef L. Coronal approach for rehabilitative orbital decompression in Graves' ophthalmopathy. Br J Ophthalmol. 1997;81:41-45.
22. Linnet J, Hegedus L, Bjerre P. Results of a neurosurgical two-wall orbital decompression in the treatment of severe thyroid associated ophthalmopathy. Acta Ophthalmol Scand. 2001;79:49-52.
23. Seiff SR, Tovilla SJ, Carter SR, Choo PH. Modified orbital decompression for dysthyroid orbitopathy. Ophthal Plast Reconstr Surg. 2000;16:62-66.
24. Shepard KG, Levin PS, Terris DJ. Balanced orbital decompression for Graves' ophthalmopathy. Laryngoscope. 1998;108:1648-1653.
25. Unal M, Lery F, Konuk O, Hasanreisoglu B. Balanced orbital decompression combined with fat removal in Graves ophthalmopathy: do we really need to remove the third wall? Ophthal Plast Reconstr Surg. 2003;19:112-118.
26. Wright ED, Davidson J, Codere F, Desrosiers M. Endoscopic orbital decompression with preservation of an inferomedial bony strut: minimization of postoperative diplopia. J Otolaryngol. 1999;28:252-256.
27. Trokel S, Kazim M, Moore S. Orbital fat removal: decompression for Graves' orbitopathy. Ophthalmology. 1993;100:674-682.
28. Michel O, Oberlander N, Neugebauer P, Neugebauer A, Rubmann W. Follow-up of transnasal orbital decompression in severe Graves' ophthalmopathy. Ophthalmology. 2001;108:400-404.
29. Bartalena L, Marcocci C, Pinchera A. Treating severe Graves' ophthalmopathy. Baillieres Clin Endocrinol Metab. 1997;11:521-536.
30. Soares-Welch C, Fatourechi V, Bartley GB, et al. Optic neuropathy of Graves disease: results of transantral orbital decompression and long-term follow-up in 215 patients. Am J Ophthalmol. 2003;136:433-441.
31. Fatourechi V, Garrity JA, Bartley GB, Bergstralh EJ, Desanto LW, Gorman CA. Graves ophthalmopathy: results of transantral orbital decompression performed primarily for cosmetic indications. Ophthalmology. 1994;101:938-942.
32. Metson R, Samaha M. Reduction of diplopia following endoscopic orbital decompression: the orbital sling technique. Laryngoscope. 2002;112:1753-1757.
33. Ben Simon G, Wang L, McCann JD, Goldberg RA. Primary-gaze diplopia in thyroidrelated orbitopathy patients undergoing deep lateral orbital decompression with intraconal fat debulking. Thyroid. 2004;14:379-383.
34. Shorr N, Seiff SR. The four stages of surgical rehabilitation of the patient with dysthyroid ophthalmopathy. Ophthalmology. 1986;93:476-483.